Matches in SemOpenAlex for { <https://semopenalex.org/work/W2364694726> ?p ?o ?g. }
Showing items 1 to 84 of
84
with 100 items per page.
- W2364694726 endingPage "4" @default.
- W2364694726 startingPage "310" @default.
- W2364694726 abstract "A dominant H-2d restricted Th epitope P34 was found to be contained in recombinant particulate hepatitis E virus (HEV) vaccine HEV 239. In this paper, the cellular immune response induced in P34 immunized BALB/c mice were studied and the priming effect of P34 was characterized. Groups of BALB/c mice were subcutaneously (s. c.) immunized with P34, splenocytes were then stimulated with P34 and HEV 239 protein, cellular immune response was assayed by IFN-gamma-ELISPOT, flow cytometry and T cell proliferation experiments. Results showed that P34 immunized BALB/c splenocytes responsed to P34 and HEV 239 protein stimulation in IFN-gamma-ELISPOT, flow cytometry and T cell proliferation experiments. After depletion of the CD4+ T cells from the immunized splenocytes by magnetic separation, the response decreased to the background level while almost no influence was observed after CD8 + T cells depletion which showed that the cells responsible for IFN-gamma secretion were mainly CD4+ T cells. Then mice were primed with P34 and boosted with its vector protein, E2, the E2 specific antibody titer were assayed. Results showed that after P34 priming, some of the 10 microg, 20 microg E2 boosted mice could develop anti-E2 antibody 1 week later and all the mice had detectable antibody 3 weeks after boosting. In the control peptide P18 priming group, even after boosting with 20 microg E2, anti-E2 antibody couldn't be detected until the end of this experiment. The results showed that priming with P34 epitope could increase the immunogenicity of its vector protein, E2, in BALB/c mice." @default.
- W2364694726 created "2016-06-24" @default.
- W2364694726 creator A5001154983 @default.
- W2364694726 creator A5002765396 @default.
- W2364694726 creator A5006532766 @default.
- W2364694726 creator A5040934431 @default.
- W2364694726 creator A5070168366 @default.
- W2364694726 creator A5071672663 @default.
- W2364694726 creator A5078732636 @default.
- W2364694726 creator A5086284188 @default.
- W2364694726 date "2007-03-01" @default.
- W2364694726 modified "2023-09-23" @default.
- W2364694726 title "[Priming with an HEV Th epitope can improve the humoral immunogenicity of its native protein]." @default.
- W2364694726 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17460907" @default.
- W2364694726 hasPublicationYear "2007" @default.
- W2364694726 type Work @default.
- W2364694726 sameAs 2364694726 @default.
- W2364694726 citedByCount "0" @default.
- W2364694726 crossrefType "journal-article" @default.
- W2364694726 hasAuthorship W2364694726A5001154983 @default.
- W2364694726 hasAuthorship W2364694726A5002765396 @default.
- W2364694726 hasAuthorship W2364694726A5006532766 @default.
- W2364694726 hasAuthorship W2364694726A5040934431 @default.
- W2364694726 hasAuthorship W2364694726A5070168366 @default.
- W2364694726 hasAuthorship W2364694726A5071672663 @default.
- W2364694726 hasAuthorship W2364694726A5078732636 @default.
- W2364694726 hasAuthorship W2364694726A5086284188 @default.
- W2364694726 hasConcept C100701293 @default.
- W2364694726 hasConcept C153911025 @default.
- W2364694726 hasConcept C159047783 @default.
- W2364694726 hasConcept C159654299 @default.
- W2364694726 hasConcept C167672396 @default.
- W2364694726 hasConcept C189976730 @default.
- W2364694726 hasConcept C195616568 @default.
- W2364694726 hasConcept C203014093 @default.
- W2364694726 hasConcept C22889606 @default.
- W2364694726 hasConcept C2776090121 @default.
- W2364694726 hasConcept C2779053233 @default.
- W2364694726 hasConcept C2780868878 @default.
- W2364694726 hasConcept C32611913 @default.
- W2364694726 hasConcept C553184892 @default.
- W2364694726 hasConcept C59822182 @default.
- W2364694726 hasConcept C81444415 @default.
- W2364694726 hasConcept C86803240 @default.
- W2364694726 hasConcept C8891405 @default.
- W2364694726 hasConceptScore W2364694726C100701293 @default.
- W2364694726 hasConceptScore W2364694726C153911025 @default.
- W2364694726 hasConceptScore W2364694726C159047783 @default.
- W2364694726 hasConceptScore W2364694726C159654299 @default.
- W2364694726 hasConceptScore W2364694726C167672396 @default.
- W2364694726 hasConceptScore W2364694726C189976730 @default.
- W2364694726 hasConceptScore W2364694726C195616568 @default.
- W2364694726 hasConceptScore W2364694726C203014093 @default.
- W2364694726 hasConceptScore W2364694726C22889606 @default.
- W2364694726 hasConceptScore W2364694726C2776090121 @default.
- W2364694726 hasConceptScore W2364694726C2779053233 @default.
- W2364694726 hasConceptScore W2364694726C2780868878 @default.
- W2364694726 hasConceptScore W2364694726C32611913 @default.
- W2364694726 hasConceptScore W2364694726C553184892 @default.
- W2364694726 hasConceptScore W2364694726C59822182 @default.
- W2364694726 hasConceptScore W2364694726C81444415 @default.
- W2364694726 hasConceptScore W2364694726C86803240 @default.
- W2364694726 hasConceptScore W2364694726C8891405 @default.
- W2364694726 hasIssue "2" @default.
- W2364694726 hasLocation W23646947261 @default.
- W2364694726 hasOpenAccess W2364694726 @default.
- W2364694726 hasPrimaryLocation W23646947261 @default.
- W2364694726 hasRelatedWork W104270335 @default.
- W2364694726 hasRelatedWork W1540832725 @default.
- W2364694726 hasRelatedWork W1944934925 @default.
- W2364694726 hasRelatedWork W1999316098 @default.
- W2364694726 hasRelatedWork W2045884759 @default.
- W2364694726 hasRelatedWork W2083087192 @default.
- W2364694726 hasRelatedWork W2155999541 @default.
- W2364694726 hasRelatedWork W2364694726 @default.
- W2364694726 hasRelatedWork W2376606906 @default.
- W2364694726 hasRelatedWork W2394857082 @default.
- W2364694726 hasVolume "23" @default.
- W2364694726 isParatext "false" @default.
- W2364694726 isRetracted "false" @default.
- W2364694726 magId "2364694726" @default.
- W2364694726 workType "article" @default.